o adults (age ≥18 years, which allows consent), o recently hospitalised (or already in hospital) with laboratory-confirmed COVID, o not expected to be transferred within 72 hours, o with, in the view of their doctors, no contra-indication to any potentially relevant study drug.

o adults (age ≥18 years, which allows consent), o recently hospitalised (or already in hospital) with laboratory-confirmed COVID, o not expected to be transferred within 72 hours, o with, in the view of their doctors, no contra-indication to any potentially relevant study drug.

Consenting adults (age ≥18) Hospitalised with definite COVID-19, not already receiving any of the study drugs, without known allergy or contra-indications to any of them (in the view of the physician responsible for their care), and without anticipated transfer within 72 hours to a non-study hospital.

Consenting adults (age ≥18) Hospitalised with definite COVID-19, not already receiving any of the study drugs, without known allergy or contra-indications to any of them (in the view of the physician responsible for their care), and without anticipated transfer within 72 hours to a non-study hospital.

consenting adults (age ≥18) hospitalised with definite COVID-19, not already receiving any of the study drugs

consenting adults (age ≥18) hospitalised with definite COVID-19, not already receiving any of the study drugs